[1] Although they are often discussed in the context of myocardial infarction, other conditions can lead to an elevation in cardiac marker level.

In many cases medical societies advise doctors to make biomarker measurements an initial testing strategy especially for patients at low risk of cardiac death.

[7] Recently, the intentional destruction of myocardium by alcohol septal ablation has led to the identification of additional potential markers.

GP-BB is one of the "new cardiac markers" which are considered to improve early diagnosis in acute coronary syndrome.

Additionally, determining the levels of cardiac markers in the laboratory - like many other lab measurements - takes substantial time.